首页> 外文期刊>Nature clinical practice. Rheumatology >Thalidomide for rheumatic disease: the best of both worlds?
【24h】

Thalidomide for rheumatic disease: the best of both worlds?

机译:沙利度胺治疗风湿病:两全其美?

获取原文
获取原文并翻译 | 示例
           

摘要

As rheumatologists, each of us is keenly aware of the fine balance between therapeutic suppression of inflammatory reactions to prevent tissue damage and the corresponding increased risk of severe infection. A variety of biologic agents are now available that interfere with tumor necrosis factor (TNF) or interleukin (IL) -1 (3, and additional agents that block IL-6 are likely to be available in the near future.
机译:作为风湿病学家,我们每个人都敏锐地意识到治疗性炎性反应抑制(以防止组织损伤)与相应的严重感染风险增加之间的良好平衡。现在可以使用多种干扰肿瘤坏死因子(TNF)或白介素(IL)-1(3)的生物制剂,另外在不久的将来可能会出现其他阻断IL-6的制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号